EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer

Tatyana Gavrikova, Naohiko Nakamura iD, Julia Davydova, Emmanuel S Antonarakis, Masato Yamamoto

Viruses · 2023

DOI: 10.3390/v15040901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Tatyana Gavrikova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Gene Therapy, Department of Surgery, Medicine and Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Adenoviridae, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, DOD PCRP DAMD17-03-1-0104.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The development of conditionally replicative adenoviruses (CRAds) for castration-resistant prostate cancer (CRPC), particularly neuroendocrine prostate cancer (NEPC), has two major obstacles: choice of control element and poor infectivity. We applied fiber-modification-based infectivity enhancement and an androgen-independent promoter (cyclooxynegase-2, COX-2) to overcome these issues.

Methods

The properties of the COX-2 promoter and the effect of fiber modification were tested in two CRPC cell lines (Du-145 and PC3). Fiber-modified COX-2 CRAds were tested in vitro for cytocidal effect as well as in vivo for antitumor effect with subcutaneous CRPC xenografts.

Results

In both CRPC cell lines, the COX-2 promoter showed high activity, and Ad5/Ad3 fiber modification significantly enhanced adenoviral infectivity. COX-2 CRAds showed a potent cytocidal effect in CRPC cells with remarkable augmentation by fiber modification. In vivo, COX-2 CRAds showed an antitumor effect in Du-145 while only Ad5/Ad3 CRAd showed the strongest antitumor effect in PC3.

Conclusion

COX-2 promoter–based, infectivity-enhanced CRAds showed a potent antitumor effect in CRPC/NEPC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenoviridaeProstatic Neoplasms, Castration-ResistantHumansMaleCyclooxygenase 2Virus ReplicationCell LineCell Line, Tumor

Stichwörter der Autor:innen

NEPCadenoviralcastration resistantcyclooxygenaseneuroendocrinal prostate cancerprostate cancerreplicativevirotherapy

Substanzen

Cyclooxygenase 2

Autor:innen und Institutionen

  • Division of Human Gene Therapy, Department of Surgery, Medicine and Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

ORCID-Profile: Naohiko Nakamura

Förderung

  • NCI NIH HHS
  • NIH HHS
  • DOD PCRP DAMD17-03-1-0104
  • NIH/NCI R01CA228760
  • NIH/NCI R01CA276480

Zitieren

APA

Gavrikova, T., Nakamura, N., Davydova, J., Antonarakis, E. S., & Yamamoto, M. (2023). Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer. Viruses. https://doi.org/10.3390/v15040901

Vancouver

Gavrikova T, Nakamura N, Davydova J, Antonarakis ES, Yamamoto M. Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer. Viruses. 2023. doi:10.3390/v15040901

BibTeX
@article{Gavrikova2023,
  author = {Gavrikova, Tatyana and Nakamura, Naohiko and Davydova, Julia and Antonarakis, Emmanuel S and Yamamoto, Masato},
  title = {Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040901}
}
Kostenlos starten →